A Paper published in Journal of Bodywork and Movement Therapies – Volume 14, Issue 1, Pages 3-12, January 2010 – Fascia: A missing link in our understanding of the pathology of fibromyalgia by Ginevra L. Liptan supports what we already know that fibromyalgia can be helped by using TRE®. Here is an abstract from the paper supporting our views:
“There is some evidence that there is a dysfunction of the intramuscular connective tissue, or fascia, in fibromyalgia. A recent medical paper proposes that inflammation of the fascia is the source of peripheral nociceptive input that leads to central sensitization in fibromyalgia. The fascial dysfunction is proposed to be due to inadequate growth hormone production and HPA (Hypothalamic/Pituitary/Adrenal) axis dysfunction in fibromyalgia.
The inflammation of the fascia is similar to that described in conditions such as plantar fasciitis and may be better described as a dysfunctional healing response. This may explain why NSAIDs and oral steroids have not been found effective in fibromyalgia.
Inflammation and dysfunction of the fascia may lead to central sensitization in fibromyalgia. If this hypothesis is confirmed, it could significantly expand treatment options to include manual therapies directed at the fascia such as Rolfing and myofascial release like TRE®, and direct further research on the peripheral pathology in fibromyalgia to the fascia.”
As TRE® is a myofascial release it can help relieve the pain and tension that causes fibromyalgia. Get shaking now!